Side-by-side comparison of AI visibility scores, market position, and capabilities
Tempe AZ small business internet platform (NYSE: GDDY) $4.6B FY2024 revenue (+7%); 84M+ domains, GoDaddy Airo AI business creation, Applications & Commerce double-digit growth competing with Squarespace and Wix.
GoDaddy Inc. is a Tempe, Arizona-based internet domain registrar and small business platform company — publicly traded on the New York Stock Exchange (NYSE: GDDY) as an S&P 500 Information Technology component — providing domain name registration, web hosting, website building, email marketing, e-commerce tools, and payment processing to approximately 21 million customers worldwide through approximately 6,000 employees. In fiscal year 2024, GoDaddy reported revenues of $4.6 billion (+7% year-over-year), with the Applications and Commerce segment (website builders, e-commerce, email marketing, payment tools) growing at double-digit rates as GoDaddy shifted its revenue mix from commodity domain registration (low-margin, high-volume) toward higher-value SaaS subscription products that generate $20-80/month per customer versus $1-2/month from domain registration alone. CEO Aman Bhutani has executed GoDaddy Airo — an AI-powered business creation assistant that automatically generates a customized website, logo, professional email, social media profiles, and marketing content from a single business description prompt — positioning GoDaddy as the AI-first small business launch platform that reduces the time from business idea to online presence from days to minutes. GoDaddy Airo (launched 2024 at the US launch, expanding internationally) differentiates from Squarespace, Wix, and Shopify by automating the entire digital business setup workflow rather than providing only a website builder — enabling GoDaddy to capture a higher share of new business formation activity as the first-touch AI assistant that creates the domain, website, email, and marketing assets simultaneously.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.